ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Study Seeks Newly Diagnosed Prostate Cancer Patients

March 26, 2010

NCAB Approves Characteristics for Recognition As Comprehensive; Outlook Dim for New Division

May 19, 1989

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

CCIRC Reviews Two Existing, One Prospective Cooperative Group

March 4, 1977

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

Senate, House Budget Plans Likely To Result In Modest Funding Increases For NIH, NCI

May 11, 1990